Speak with our experts at World CDx Europe on making biomarkers and diagnostics a precision medicine reality. With access to both banked and custom biospecimens from a myriad of disease states as well as normal biospecimens, we can help improve the development and clinical validation of novel predictive biomarker signatures. Members of our PHASEZERO® Research team will be present to discuss biomarker validation, therapy efficacy, and safety to accelerate the commercialization of diagnostic-enabled personalized medicines. By combining our technical expertise, exceptional customer service, and unparalleled access to biological specimens, BioIVT serves the research community as a trusted partner in ELEVATING SCIENCE®.
April 17th, 12:00 pm
Development of Multiplex IHC Targeting Biomarket Identification
– Madhu Das, Senior Scientist